First Affiliated Hospital of Wenzhou Medical University
People's Republic of China
- Country
- People's Republic of China
- Ownership
- Private
- Established
- 1956-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.dyyy.xjtu.edu.cn/
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
Phase 4
Recruiting
- Conditions
- Nonalcoholic Fatty Liver DiseaseChronic Hepatitis b
- Interventions
- Drug: Peg-Interferon α
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2024-04-16
- Target Recruit Count
- 1500
- Registration Number
- NCT06368882
- Locations
- 🇨🇳
Ningbo No.2 Hospital, Ningbo, China
🇨🇳Ruian People's Hospital, Rui'an, China
🇨🇳The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography
Not yet recruiting
- Conditions
- Portal HypertensionCirrhosis
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2024-03-19
- Target Recruit Count
- 216
- Registration Number
- NCT06316869
- Locations
- 🇨🇳
the First Affiliated Hospital the First Affiliated Hospital, Wenzhou, Zhejiang, China
Assessing Diabetic Foot Ulcer Microcirculation With High-frequency Contrast Enhanced Ultrasound
Not yet recruiting
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2024-10-29
- Target Recruit Count
- 100
- Registration Number
- NCT06309082
- Locations
- 🇨🇳
the First Affiliated Hospital the First Affiliated Hospital, Wenzhou, Zhejiang, China
Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC
Phase 2
Not yet recruiting
- Conditions
- Gastric Cancer
- Interventions
- First Posted Date
- 2024-02-02
- Last Posted Date
- 2024-02-02
- Target Recruit Count
- 40
- Registration Number
- NCT06238167
Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors
Completed
- Conditions
- AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
- Interventions
- Drug: ICIsDrug: AntiVEGF
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-08
- Target Recruit Count
- 1581
- Registration Number
- NCT06119347
- Locations
- 🇨🇳
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Effectiveness and Safety of Danshen Injection for Acute Kidney Injury in Primary Nephrotic Syndrome
Completed
- Conditions
- Nephrotic SyndromeNephropathyAcute Kidney Injury
- Interventions
- Drug: Dandshen
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2023-10-10
- Target Recruit Count
- 441
- Registration Number
- NCT06071533
- Locations
- 🇨🇳
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection
Not Applicable
Recruiting
- Conditions
- Photodynamic TherapyHPV-Related Cervical CarcinomaHPV InfectionLow-Grade Squamous Intraepithelial Lesions
- Interventions
- Procedure: CO2
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2025-05-13
- Target Recruit Count
- 40
- Registration Number
- NCT06052033
- Locations
- 🇨🇳
first affiliated hospital of Wenzhou medical university, Wenzhou, Zhejiang, China
The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy
Phase 4
Recruiting
- Conditions
- Diabetic Peripheral Neuropathy
- Interventions
- Drug: hypoglycemic Agents(metformin)Drug: lipid-lowering drug(Statin)
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2023-09-18
- Target Recruit Count
- 1400
- Registration Number
- NCT06041399
- Locations
- 🇨🇳
First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy
Recruiting
- Conditions
- Diabetic Peripheral Neuropathy
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2023-09-18
- Target Recruit Count
- 1400
- Registration Number
- NCT06041412
- Locations
- 🇨🇳
First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Early and Late Prognosis in Patients With Guillain-Barre Syndrome
Phase 4
Recruiting
- Conditions
- Guillain-Barre Syndrome
- Interventions
- Drug: Intravenous Immunoglobulins, Human
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2023-09-18
- Target Recruit Count
- 450
- Registration Number
- NCT06041451
- Locations
- 🇨🇳
First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
© Copyright 2025. All Rights Reserved by MedPath